4.3 Review

How important is age in defining the prognosis of patients with community-acquired pneumonia?

Journal

CURRENT OPINION IN INFECTIOUS DISEASES
Volume 24, Issue 2, Pages 142-147

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QCO.0b013e328343b6f8

Keywords

age; health-related outcome; mortality; pneumonia

Ask authors/readers for more resources

Purpose of review Given that the population is increasing in age, a better understanding of the relationship between chronological age and health-related outcomes (especially mortality) is needed, for both chronic diseases (e. g. diabetes) and acute illnesses (e. g. pneumonia). Our purpose was to review the impact of age on the prognosis of patients with community-acquired pneumonia (CAP). Recent findings Many studies in patients with CAP have suggested that chronological age is not necessarily independently associated with mortality. Poorer outcomes in the elderly with CAP have been related to severity of disease, comorbid disease burden, functional status, and frailty, but not to age alone. However, many of these studies suffer from 'over-adjustment' due to the use of unmodified severity scores such as the Pneumonia Severity Index or Acute Physiology and Chronic Health Evaluation II (that already include age) in multivariable analyses. Studies accounting for this over-adjustment suggest that age is, in fact, independently associated with mortality in hospitalized patients with CAP. Other outcomes including hospitalization and readmission rates, hospital length of stay, and cost of care are similarly associated with increasing age. Residual confounding is still a problem in many of the observational studies reviewed. Summary Contrary to conventional wisdom, chronological age is independently associated with adverse outcomes in patients with CAP. Until better methods (or more clinically-rich datasets) for observational studies are developed that can avoid over-adjustment and better deal with residual confounding, physicians should take into account both a patient's overall health status and his or her chronological age.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

Karim Ali, Tanweer Azher, Mahin Baqi, Alexandra Binnie, Sergio Borgia, Francois M. Carrier, Yiorgos Alexandros Cavayas, Nicolas Chagnon, Matthew P. Cheng, John Conly, Cecilia Costiniuk, Peter Daley, Nick Daneman, Josh Douglas, Catarina Downey, Erick Duan, Emmanuelle Duceppe, Madeleine Durand, Shane English, George Farjou, Evradiki Fera, Patricia Fontela, Rob Fowler, Michael Fralick, Anna Geagea, Jennifer Grant, Luke B. Harrison, Thomas Havey, Holly Hoang, Lauren E. Kelly, Yoav Keynan, Kosar Khwaja, Gail Klein, Marina Klein, Christophe Kolan, Nadine Kronfli, Francois Lamontagne, Michael Lau, Todd C. Lee, Nelson Lee, Rachel Lim, Sarah Longo, Alexandra Lostun, Erika MacIntyre, Isabelle Malhame, Kathryn Mangoff, Marlee McGuinty, Sonya Mergler, Matthew Munan, Srinivas Murthy, Conar O'Neil, Daniel Ovakim, Jesse Papenburg, Ken Kuljit S. Parhar, Seema Nair Parvathy, Chandni Patel, Santiago Perez-Patrigeon, Ruxandra Pinto, Subitha Rajakumaran, Asgar Rishu, Malaika Roba-Oshin, Moira Rushton, Mariam Saleem, Marina Salvadori, Kim Scherr, Kevin Schwartz, Makeda Semret, Michael Silverman, Ameeta Singh, Wendy Sligl, Stephanie Smith, Ranjani Somayaji, Darrell H. S. Tan, Siobhan Tobin, Meaghan Todd, Tuong-Vi Tran, Alain Tremblay, Jennifer Tsang, Alexis Turgeon, Erik Vakil, Jason Weatherald, Cedric Yansouni, Ryan Zarychanski

Summary: This Canadian study explores the effectiveness of remdesivir as a treatment for COVID-19. The results show that remdesivir has a modest but significant impact on important outcomes for patients and healthcare systems, such as the need for mechanical ventilation.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2022)

Review Infectious Diseases

Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis

Ruwandi M. Kariyawasam, Tanis C. Dingle, Brittany E. Kula, Ben Vandermeer, Wendy Sligl, Ilan S. Schwartz

Summary: The prevalence, diagnosis, treatment, and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA) are poorly understood, and there are discordant definitions across studies, potentially leading to an overestimation of reported prevalence.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Peripheral Vascular Disease

Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries

Kaiming Wang, Mahmoud Gheblawi, Anish Nikhanj, Matt Munan, Erika MacIntyre, Conar O'Neil, Marko Poglitsch, Daniele Colombo, Franca Del Nonno, Zamaneh Kassiri, Wendy Sligl, Gavin Y. Oudit

Summary: The dysregulation of ACE2 and angiotensin levels in COVID-19 patients is associated with adverse outcomes, suggesting potential therapeutic strategies for improving outcomes against SARS-CoV-2 infection.

HYPERTENSION (2022)

Editorial Material Biochemistry & Molecular Biology

Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19

Philippe Begin, Jeannie Callum, Richard Cook, Erin Jamula, Yang Liu, Andres Finzi, Donald M. Arnold

NATURE MEDICINE (2022)

Article Critical Care Medicine

Needs Assessment Survey Identifying Research Processes Which may be Improved by Automation or Artificial Intelligence: ICU Community Modeling and Artificial Intelligence to Improve Efficiency (ICU-Comma)

Vincent Lau, Alexandra Binnie, John Basmaji, Nadia Baig, Dawn Opgenorth, Saoirse Cameron, Katie O'Hearn, Ellen McDonald, Janek Senaratne, Wendy Sligl, Danny J. Zuege, Oleksa Rewa, Sean M. Bagshaw, Jennifer Tsang

Summary: The survey of Canadian ICU research personnel found that tasks like screening for eligible patients, inputting data into case report forms, and preparing internal tracking logs were considered time-consuming and tedious. Respondents believed that AI automation could improve efficiency and accuracy in these tasks, while also freeing up research coordinators to focus on tasks that require human interaction. However, challenges such as ensuring information accuracy and proper oversight were also highlighted when considering AI automation in ICU research.

JOURNAL OF INTENSIVE CARE MEDICINE (2022)

Article Medicine, Research & Experimental

LIBERATE: a study protocol for midodrine for the early liberation from vasopressor support in the intensive care unit (LIBERATE): protocol for a randomized controlled trial

Dawn Opgenorth, Nadia Baig, Kirsten Fiest, Constantine Karvellas, Jim Kutsogiannis, Vincent Lau, Erika Macintyre, Janek Senaratne, Jocelyn Slemko, Wendy Sligl, Xiaoming Wang, Sean M. Bagshaw, Oleksa G. Rewa

Summary: The LIBERATE study aims to evaluate the effect of oral midodrine on ICU length of stay and duration of IV vasopressor support in critically ill patients, as well as other outcome measures related to IV vasopressor therapy.

TRIALS (2022)

Article Microbiology

Differential Impact of SARS-CoV-2 Isolates, Namely, the Wuhan Strain, Delta, and Omicron Variants on Erythropoiesis

Suguru Saito, Shima Shahbaz, Wendy Sligl, Mohammed Osman, D. Lorne Tyrrell, Shokrollah Elahi

Summary: This study reveals that SARS-CoV-2 variants have differential impacts on erythropoiesis, with CD45(+) erythroid cells exhibiting immunosuppressive properties and potentially contributing to anemia in COVID-19 patients. The findings provide important insights into the understanding of the effects of SARS-CoV-2 variants on erythropoiesis.

MICROBIOLOGY SPECTRUM (2022)

Article Critical Care Medicine

Variation in communication and family visiting policies in intensive care within and between countries during the Covid-19 pandemic: The COVISIT international survey

Alexis Tabah, Muhammed Elhadi, Emma Ballard, Andrea Cortegiani, Maurizio Cecconi, Takeshi Unoki, Laura Galarza, Regis Goulart Rosa, Francois Barbier, Elie Azoulay, Kevin B. Laupland, Nathalie Ssi Yan Kai, Marlies Ostermann, Guy Francois, Jan J. De Waele, Kirsten Fiest, Peter Spronk, Julie Benbenishty, Mariangela Pellegrini, Louise Rose

Summary: During the COVID-19 pandemic, ICU implemented restrictive visiting policies and relied on telephone and virtual visits for communication. These policies have gradually been liberalized but have not returned to pre-pandemic practices.

JOURNAL OF CRITICAL CARE (2022)

Review Immunology

Hyperammonemia syndrome post-lung transplantation: Case series and systematic review of literature

Bruno Fernando Buzo, Jutta K. Preiksaitis, Kieran Halloran, Jayan Nagendran, Derek R. Townsend, Nathan Zelyas, Wendy I. Sligl

Summary: This case series and literature review provide insights into hyperammonemia syndrome (HS) after lung transplant, highlighting the association with Ureaplasma spp. and Mycoplasma hominis infections. The findings emphasize the importance of early testing and treatment for these infections.

TRANSPLANT INFECTIOUS DISEASE (2022)

Article Immunology

Differential effects of age, sex and dexamethasone therapy on ACE2/TMPRSS2 expression and susceptibility to SARS-CoV-2 infection

Shima Shahbaz, Olaide Oyegbami, Suguru Saito, Mohammed Osman, Wendy Sligl, Shokrollah Elahi

Summary: ACE2 and TMPRSS2 are crucial for SARS-CoV-2 entry into the cell. Loss of ACE2 leads to severe clinical symptoms of COVID-19. In this study, it was found that ACE2 expression was significantly higher in the lung and heart tissues of neonatal mice compared to adults, while TMPRSS2 expression was developmentally regulated. ACE2 expression was also upregulated in adult female lungs compared to males. Dexamethasone treatment increased ACE2 and TMPRSS2 expression in both neonatal and adult mice, enhancing infection with SARS-CoV-2. These findings suggest that individuals taking dexamethasone may be more susceptible to SARS-CoV-2 infection.

FRONTIERS IN IMMUNOLOGY (2022)

Article Critical Care Medicine

Clostridioides difficile infection in mechanically ventilated critically ill patients: A nested cohort study

Joanna C. Dionne, Jennie Johnstone, Diane Heels-Ansdell, Erick Duan, Francois Lauzier, Yaseen M. Arabi, Neill K. J. Adhikari, Wendy Sligl, Peter Dodek, Bram Rochwerg, John C. Marshall, Daniel J. Niven, David R. Williamson, Steven Reynolds, Nicole Zytaruk, Deborah Cook

Summary: This nested cohort study examined the incidence, prevalence, timing, severity, predictors, and outcomes of Clostridioides difficile infection (CDI) among critical illness patients. The results showed a low incidence and prevalence of CDI, with mild to moderate severity. CDI was not associated with hospital mortality but was associated with a longer hospital stay.

JOURNAL OF CRITICAL CARE (2023)

Review Medicine, General & Internal

Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis

Mostafa Kamaleldin, Sebastian Kilcommons, Dawn Opgenorth, Kirsten Fiest, Constantine Jason Karvellas, Jim Kutsogiannis, Vincent Lau, Erika MacIntyre, Bram Rochwerg, Janek Senaratne, Jocelyn Slemko, Wendy Sligl, Xiaoming Wang, Sean M. Bagshaw, Oleksa G. Rewa

Summary: This systematic review aims to evaluate the efficacy of midodrine in vasopressor dependent shock, by conducting a review and analysis of observational trials and randomized controlled trials, assessing its impact on ICU length of stay, duration of intravenous vasopressor support, ICU and hospital mortality, hospital length of stay, and rates of ICU readmission.

BMJ OPEN (2022)

Article Critical Care Medicine

IV Vitamin C in Adults With Sepsis: A Bayesian Reanalysis of a Randomized Controlled Trial*

Federico Angriman, Fiona Muttalib, Francois Lamontagne, Neill K. J. Adhikari, LOVIT Invest

Summary: The Lessening Organ Dysfunction with Vitamin C trial showed that vitamin C has a harmful effect on 28-day death or persistent organ dysfunction. A post hoc Bayesian reanalysis confirmed that there is a high probability of harm in using vitamin C for adult patients with infection and vasopressor support.

CRITICAL CARE MEDICINE (2023)

Article Critical Care Medicine

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Alexis Tabah, Niccolo Buetti, Quentin Staiquly, Stephane Ruckly, Murat Akova, Abdullah Tarik Aslan, Marc Leone, Andrew Conway Morris, Matteo Bassetti, Kostoula Arvaniti, Jeffrey Lipman, Ricard Ferrer, Haibo Qiu, Jose-Artur Paiva, Pedro Povoa, Liesbet De Bus, Jan De Waele, Farid Zand, Mohan Gurjar, Adel Alsisi, Khalid Abidi, Hendrik Bracht, Yoshiro Hayashi, Kyeongman Jeon, Muhammed Elhadi, Francois Barbier, Jean-Francois Timsit

Summary: This study investigated hospital-acquired bloodstream infections (HA-BSI) in 2600 adult patients from 333 ICUs in 52 countries. HA-BSI were frequently caused by Gram-negative, carbapenem-resistant, and difficult-to-treat pathogens. Antimicrobial resistance led to delays in adequate antimicrobial therapy, resulting in high mortality rates.

INTENSIVE CARE MEDICINE (2023)

Article Critical Care Medicine

Definitions, rates and associated mortality of ICU-acquired pneumonia: A multicenter cohort study

Jennie Johnstone, John Muscedere, Joanna Dionne, Erick Duan, Bram Rochwerg, John Centofanti, Simon Oczkowski, Francois Lauzier, John Marshall, Diane Heels-Ansdell, Nick Daneman, Sangeeta Mehta, Yaseen Arabi, Nicole Zytaruk, Peter Dodek, Neill K. Adhikari, Tim Karachi, Emmanuel Charbonney, Henry T. Stelfox, Arnold S. Kristof, Ian Ball, Lori Hand, Rob Fowler, Ryan Zarychanski, Charles St Arnaud, Alyson Takaoka, James Kutsogiannis, Kosar Khwaja, Wendy Sligl, Osama Loubani, Jennifer Tsang, Daphnee Lamarche, Dawn Bowdish, Michael Surette, Deborah Cook

Summary: This study aimed to analyze ICU-acquired pneumonia according to 7 definitions and estimate associated hospital mortality. The results showed that the frequency of ICU-acquired pneumonia varied by definition, and it was associated with differential increased risk of death.

JOURNAL OF CRITICAL CARE (2023)

No Data Available